Matthew E. Korenberg, EVP, Finance & Strategy and CFO at LIGAND PHARMACEUTICALS INC (LGND), bought 500 shares at $86.18 ($43K) on 2019-09-03, disclosed to the SEC on 2019-09-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| LGND | SELL | 2024-08-13 | $3.6M | — | Filing → |
| LGND | SELL | 2024-05-15 | $2.9M | — | Filing → |
| LGND | SELL | 2018-08-29 | $9.4M | — | Filing → |